Circulating suPAR in Relation to Renal and Cardiovascular Involvement in Systemic Lupus Erythematosus: A Pilot Study. [PDF]
Napolitano F +5 more
europepmc +1 more source
Elevated Soluble Urokinase-Type Plasminogen Activator Receptor Levels, Organ Dysfunction, and Death in Children Hospitalized With Malaria: Considerations for Use as a Risk Stratification Tool. [PDF]
Ssuuna C +11 more
europepmc +1 more source
Maternal soluble urokinase plasminogen activator receptor levels in intrahepatic cholestasis of pregnancy: a predictor of neonatal intensive care unit admission. [PDF]
Aktaş BA +7 more
europepmc +1 more source
Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) as a Biomarker of Neurodysfunction. [PDF]
de Rezende VL +4 more
europepmc +1 more source
Serum profiling of uPA, PAI-1, and suPAR in systemic sclerosis: a preliminary study on analytical aspects and associations with microvascular and fibrotic manifestations. [PDF]
Napolitano F +5 more
europepmc +1 more source
Plasminogen activator, urokinase receptor (PLAUR; UPAR) [PDF]
openaire +1 more source
Transdiagnostic determinants of Growth Differentiation Factor-15 (GDF-15) in psychiatric in-patients: age, renal indices, interleukin-6 (IL-6) and soluble urokinase plasminogen activator receptor (suPAR). [PDF]
Tsapakis EM +8 more
europepmc +1 more source
Hypoxia tumor-associated macrophages facilitate hepatocellular carcinoma metastasis via uPA-uPAR pathway. [PDF]
Wang Y +5 more
europepmc +1 more source
Select novel small-molecule uPA potential inhibitors as anti-cancer agents against breast cancer. [PDF]
Almosnid N +11 more
europepmc +1 more source
Urokinase Promotes Redundantly Intratubular C3a-Formation But Not ENaC-Driven Hypertension in DOCA/Salt Kidney Injury. [PDF]
Bach ML +6 more
europepmc +1 more source

